查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1387451

僵直性脊椎炎治疗市场报告：2030 年趋势、预测与竞争分析

Ankylosing Spondylitis Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

僵直性脊椎炎治疗的趋势与预测

预计到 2030 年，全球僵直性脊椎炎治疗市场将达到 84 亿美元，2024 年至 2030 年年复合成长率为 6.5%。这个市场的主要驱动因素是僵直性脊椎炎盛行率的上升、对该疾病的认识和诊断的提高以及僵直性脊椎炎治疗的进步。全球僵直性脊椎炎治疗市场前景广阔，医院药局、零售药局和线上药局市场充满机会。

僵直性脊椎炎治疗市场洞察

Lucintel 预测，由于僵直性脊椎炎的增长，非类固醇抗发炎药物在预测期内将继续占据很大一部分。

由于零售药局数量不断增加且患者更容易进入，因此零售药局仍然是市场上最大的部分。

由于老年人口不断增长和政府的支持措施，北美在预测期内可能仍然是最大的地区。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2.哪个细分市场将以更快的速度成长？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和业务风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
  • Q.11.过去年度发生了哪些併购事件，对产业产生了哪些影响？

目录

第1章执行摘要

第2章全球僵直性脊椎炎治疗市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第3章2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球僵直性脊椎炎治疗市场趋势（2018-2023）与预测（2024-2030）
  • 按药物类别分類的全球僵直性脊椎炎治疗市场
    • NSAIDs
    • 肿瘤坏死因子抑制剂
    • 其他的
  • 按销售管道分類的全球僵直性脊椎炎治疗市场
    • 医院药房
    • 零售药房
    • 线上药房

第4章2018-2030年分地区市场趋势及预测分析

  • 全球僵直性脊椎炎治疗市场区域分布
  • 北美僵直性脊椎炎治疗市场
  • 欧洲僵直性脊椎炎治疗市场
  • 亚太地区僵直性脊椎炎治疗市场
  • 其他地区僵直性脊椎炎治疗市场

第5章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第6章成长机会与策略分析

  • 成长机会分析
    • 按药物类别分類的全球僵直性脊椎炎治疗市场成长机会
    • 全球僵直性脊椎炎治疗市场成长机会（按配销通路）
    • 全球僵直性脊椎炎治疗市场按地区成长机会
  • 全球僵直性脊椎炎治疗市场的新兴趋势
  • 战略分析
    • 新产品开发
    • 扩大全球僵直性脊椎炎治疗市场的产能
    • 全球僵直性脊椎炎治疗市场的合併、收购与合资企业
    • 认证和许可

第7章主要企业概况

  • Novartis
  • Amgen
  • Boehringer Ingelheim International
  • UCB Biopharma
  • AbbVie
简介目录

Ankylosing Spondylitis Treatment Trends and Forecast

The future of the global ankylosing spondylitis treatment market looks promising with opportunities in the hospital pharmacy, retail pharmacy, and online pharmacy markets. The global ankylosing spondylitis treatment market is expected to reach an estimated $8.4 billion by 2030 with a CAGR of 6.5% from 2024 to 2030. The major drivers for this market are rising occurence of ankylosing spondylitis, growing awareness and diagnosis of condition, and advancement in ankylosing spondylitis therapy.

A more than 150-page report is developed to help in your business decisions.

Ankylosing Spondylitis Treatment by Segment

The study includes a forecast for the global ankylosing spondylitis treatment by drug class, distribution channel, and region.

Ankylosing Spondylitis Treatment Market by Drug Class [Shipment Analysis by Value from 2018 to 2030]:

  • NSAIDs
  • TNF Inhibitors
  • Others

Ankylosing Spondylitis Treatment Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

Ankylosing Spondylitis Treatment Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Ankylosing Spondylitis Treatment Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies ankylosing spondylitis treatment companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the ankylosing spondylitis treatment companies profiled in this report include-

  • Novartis
  • Amgen
  • Boehringer Ingelheim International
  • UCB Biopharma
  • AbbVie

Ankylosing Spondylitis Treatment Market Insights

Lucintel forecasts that NSAIDs will remain the larger segment over the forecast period due to growth of ankylosing spondylitis.

Within this market, retail pharmacy will remain the largest segment due to growing number of retail pharmacies and it is easy to reach for patients.

North America will remain the largest region over the forecast period due to growth of geriatric population and supportive government initiatives.

Features of the Global Ankylosing Spondylitis Treatment Market

Market Size Estimates: Ankylosing spondylitis treatment market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Ankylosing spondylitis treatment market size by drug class, distribution channel, and region in terms of value ($B).

Regional Analysis: Ankylosing spondylitis treatment market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different drug classes, distribution channels, and regions for the ankylosing spondylitis treatment market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the ankylosing spondylitis treatment market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the ankylosing spondylitis treatment market size?

Answer: The global ankylosing spondylitis treatment market is expected to reach an estimated $8.4 billion by 2030.

Q2. What is the growth forecast for ankylosing spondylitis treatment market?

Answer: The global ankylosing spondylitis treatment market is expected to grow with a CAGR of 6.5% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the ankylosing spondylitis treatment market?

Answer: The major drivers for this market are rising occurence of ankylosing spondylitis, growing awareness and diagnosis of condition, and advancement in ankylosing spondylitis therapy.

Q4. What are the major segments for ankylosing spondylitis treatment market?

Answer: The future of the ankylosing spondylitis treatment market looks promising with opportunities in the hospital pharmacy, retail pharmacy, and online pharmacy markets.

Q5. Who are the key ankylosing spondylitis treatment market companies?

Answer: Some of the key ankylosing spondylitis treatment companies are as follows:

  • Novartis
  • Amgen
  • Boehringer Ingelheim International
  • UCB Biopharma
  • AbbVie

Q6. Which ankylosing spondylitis treatment market segment will be the largest in future?

Answer: Lucintel forecasts that NSAIDs will remain the larger segment over the forecast period due to growth of ankylosing spondylitis.

Q7. In ankylosing spondylitis treatment market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to growth of geriatric population and supportive government initiatives.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the ankylosing spondylitis treatment market by drug class (NSAIDs, TNF inhibitors, and others), distribution channel (hospital pharmacy, retail pharmacy, and online pharmacy), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Ankylosing Spondylitis Treatment Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Ankylosing Spondylitis Treatment Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Ankylosing Spondylitis Treatment Market by Drug Class
    • 3.3.1: NSAIDs
    • 3.3.2: TNF Inhibitors
    • 3.3.3: Others
  • 3.4: Global Ankylosing Spondylitis Treatment Market by Distribution Channel
    • 3.4.1: Hospital Pharmacy
    • 3.4.2: Retail Pharmacy
    • 3.4.3: Online Pharmacy

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Ankylosing Spondylitis Treatment Market by Region
  • 4.2: North American Ankylosing Spondylitis Treatment Market
    • 4.2.2: North American Ankylosing Spondylitis Treatment Market by Distribution Channel: Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy
  • 4.3: European Ankylosing Spondylitis Treatment Market
    • 4.3.1: European Ankylosing Spondylitis Treatment Market by Drug Class: NSAIDs, TNF Inhibitors, and Others
    • 4.3.2: European Ankylosing Spondylitis Treatment Market by Distribution Channel: Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy
  • 4.4: APAC Ankylosing Spondylitis Treatment Market
    • 4.4.1: APAC Ankylosing Spondylitis Treatment Market by Drug Class: NSAIDs, TNF Inhibitors, and Others
    • 4.4.2: APAC Ankylosing Spondylitis Treatment Market by Distribution Channel: Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy
  • 4.5: ROW Ankylosing Spondylitis Treatment Market
    • 4.5.1: ROW Ankylosing Spondylitis Treatment Market by Drug Class: NSAIDs, TNF Inhibitors, and Others
    • 4.5.2: ROW Ankylosing Spondylitis Treatment Market by Distribution Channel: Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Ankylosing Spondylitis Treatment Market by Drug Class
    • 6.1.2: Growth Opportunities for the Global Ankylosing Spondylitis Treatment Market by Distribution Channel
    • 6.1.3: Growth Opportunities for the Global Ankylosing Spondylitis Treatment Market by Region
  • 6.2: Emerging Trends in the Global Ankylosing Spondylitis Treatment Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Ankylosing Spondylitis Treatment Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Ankylosing Spondylitis Treatment Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Novartis
  • 7.2: Amgen
  • 7.3: Boehringer Ingelheim International
  • 7.4: UCB Biopharma
  • 7.5: AbbVie